FI892312A - Expression av hepatitis b, s och pres2 proteiner i metylotropiska jaester. - Google Patents

Expression av hepatitis b, s och pres2 proteiner i metylotropiska jaester. Download PDF

Info

Publication number
FI892312A
FI892312A FI892312A FI892312A FI892312A FI 892312 A FI892312 A FI 892312A FI 892312 A FI892312 A FI 892312A FI 892312 A FI892312 A FI 892312A FI 892312 A FI892312 A FI 892312A
Authority
FI
Finland
Prior art keywords
hepatitis
pres2
methylotropiska
jaester
proteiner
Prior art date
Application number
FI892312A
Other languages
English (en)
Other versions
FI892312A0 (fi
FI104639B (fi
Inventor
Gregory Patrick Thill
Original Assignee
Phillips Petroleum Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phillips Petroleum Co filed Critical Phillips Petroleum Co
Publication of FI892312A0 publication Critical patent/FI892312A0/fi
Publication of FI892312A publication Critical patent/FI892312A/fi
Application granted granted Critical
Publication of FI104639B publication Critical patent/FI104639B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
FI892312A 1988-05-13 1989-05-12 Hepatiitti B:n S- ja PreS2 -proteiinien ilmentäminen metylotrooppisissa hiivoissa FI104639B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19371488A 1988-05-13 1988-05-13
US19371488 1988-05-13

Publications (3)

Publication Number Publication Date
FI892312A0 FI892312A0 (fi) 1989-05-12
FI892312A true FI892312A (fi) 1989-11-14
FI104639B FI104639B (fi) 2000-03-15

Family

ID=22714736

Family Applications (2)

Application Number Title Priority Date Filing Date
FI892312A FI104639B (fi) 1988-05-13 1989-05-12 Hepatiitti B:n S- ja PreS2 -proteiinien ilmentäminen metylotrooppisissa hiivoissa
FI992546A FI107265B (fi) 1988-05-13 1999-11-29 Hepatiitti B:n S- ja PreS2-proteiinien ilmentäminen metylotrofisissa hiivoissa

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI992546A FI107265B (fi) 1988-05-13 1999-11-29 Hepatiitti B:n S- ja PreS2-proteiinien ilmentäminen metylotrofisissa hiivoissa

Country Status (25)

Country Link
US (2) US5650296A (fi)
EP (1) EP0341746B1 (fi)
JP (1) JP2614314B2 (fi)
KR (1) KR100193701B1 (fi)
CN (1) CN1038668A (fi)
AT (1) ATE151109T1 (fi)
AU (1) AU618596B2 (fi)
CA (1) CA1340617C (fi)
DD (1) DD285373A5 (fi)
DE (1) DE68927921T2 (fi)
DK (1) DK235289A (fi)
ES (1) ES2101676T3 (fi)
FI (2) FI104639B (fi)
GR (1) GR3023985T3 (fi)
HU (1) HU207532B (fi)
IE (1) IE81158B1 (fi)
IL (1) IL90161A0 (fi)
IN (1) IN171696B (fi)
MX (1) MX26715A (fi)
NO (1) NO300465B1 (fi)
NZ (1) NZ228948A (fi)
PL (1) PL161997B1 (fi)
PT (1) PT90553A (fi)
YU (1) YU98689A (fi)
ZA (1) ZA893440B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032516A (en) * 1985-10-25 1991-07-16 Phillips Petroleum Company Pichia pastoris alcohol oxidase II regulatory region
PL168408B1 (pl) * 1989-08-03 1996-02-29 Smithkline Beecham Biolog Sposób wytwarzania stransformowanego mikroorganizmu PL
GB9007416D0 (en) * 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
US6197548B1 (en) 1990-04-02 2001-03-06 Medeva Pharma Limited Transformed Pichia expressing the pertactin antigen
EP0521348A1 (en) * 1991-06-18 1993-01-07 Korea Institute Of Science And Technology Chimeric antibody with specificity for hepatitis B virus pre-S2 surface antigen and cell line producing same
LT3988B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Recombinant plasmides pfs19, pfps2-48 and pjlfds1 codingsynthesis of human hepatite b of surfice virus antigenes, methods fof producing thereof
CA2101610A1 (en) * 1992-08-07 1994-02-08 William D. Prevatt Production of bacillus entomotoxins in methylotrophic yeast
GB9402832D0 (en) * 1994-02-15 1994-04-06 Smith Kline Beecham Biolog S A Novel process
US5955349A (en) * 1996-08-26 1999-09-21 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in Pichia methanolica
US5716808A (en) * 1995-11-09 1998-02-10 Zymogenetics, Inc. Genetic engineering of pichia methanolica
CA2237120C (en) * 1995-11-09 2005-03-01 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in pichia methanolica
MX9605082A (es) 1996-10-24 1998-04-30 Univ Autonoma De Nuevo Leon Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
WO2006033679A2 (en) * 2004-05-25 2006-03-30 Chimeracore, Inc. Self-assembling nanoparticle drug delivery system
CN1704475A (zh) * 2004-05-31 2005-12-07 成都生物制品研究所 羧端含前s2免疫决定簇的乙肝表面抗原融合基因及蛋白质
EP1773861A4 (en) * 2004-07-22 2008-04-16 Glycofi Inc MALATE SYNTHASE REGULATION SEQUENCES FOR THE EXPRESSION OF A HETEROLOGOUS GENE IN PICHIA
CN100381171C (zh) * 2004-12-30 2008-04-16 成都生物制品研究所 含前s1、前s2和s抗原决定簇的乙肝表面抗原复合颗粒
AU2007348315A1 (en) * 2006-04-07 2008-09-12 Chimeros, Inc. Compositions and methods for treating B- cell malignancies
US20090226525A1 (en) * 2007-04-09 2009-09-10 Chimeros Inc. Self-assembling nanoparticle drug delivery system
WO2010120874A2 (en) 2009-04-14 2010-10-21 Chimeros, Inc. Chimeric therapeutics, compositions, and methods for using same
CA2847888A1 (en) 2011-09-09 2013-03-14 Biomed Realty, L.P. Methods and compositions for controlling assembly of viral proteins
CN110066775B (zh) 2012-10-23 2024-03-19 基因工具股份有限公司 用于切割靶dna的组合物及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76274B (fi) * 1981-08-04 1984-08-04 Univ California
EP0401941A3 (en) * 1984-07-11 1991-04-17 Takeda Chemical Industries, Ltd. Hepatitis b virus surface antigen and production thereof
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
JPS62236496A (ja) * 1986-04-07 1987-10-16 Green Cross Corp:The ＨＢｓＡｇの製造方法
US4963483A (en) * 1987-10-13 1990-10-16 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
IL89991A0 (en) * 1988-04-25 1989-12-15 Phillips Petroleum Co Expression of hepatitis b pres2 protein in methylotrophic yeasts

Also Published As

Publication number Publication date
DK235289A (da) 1989-11-14
IL90161A0 (en) 1989-12-15
CA1340617C (en) 1999-06-29
PL161997B1 (pl) 1993-08-31
FI892312A0 (fi) 1989-05-12
AU618596B2 (en) 1992-01-02
US5670630A (en) 1997-09-23
HUT52557A (en) 1990-07-28
YU98689A (sh) 1992-07-20
EP0341746A3 (en) 1991-04-24
DK235289D0 (da) 1989-05-12
NZ228948A (en) 1991-06-25
DE68927921T2 (de) 1997-07-17
NO300465B1 (no) 1997-06-02
IE891563L (en) 1989-11-13
PT90553A (pt) 1989-11-30
IN171696B (fi) 1992-12-12
KR890017361A (ko) 1989-12-15
EP0341746A2 (en) 1989-11-15
GR3023985T3 (en) 1997-10-31
JP2614314B2 (ja) 1997-05-28
JPH0227990A (ja) 1990-01-30
HU207532B (en) 1993-04-28
PL279426A1 (en) 1990-01-22
CN1038668A (zh) 1990-01-10
DD285373A5 (de) 1990-12-12
NO891921L (no) 1989-11-14
ES2101676T3 (es) 1997-07-16
NO891921D0 (no) 1989-05-11
KR100193701B1 (ko) 1999-06-15
ZA893440B (en) 1990-01-31
MX26715A (es) 1993-10-01
AU3473489A (en) 1989-11-16
US5650296A (en) 1997-07-22
FI104639B (fi) 2000-03-15
FI19992546A (fi) 1999-11-29
DE68927921D1 (de) 1997-05-07
EP0341746B1 (en) 1997-04-02
ATE151109T1 (de) 1997-04-15
IE81158B1 (en) 2000-05-03
FI107265B (fi) 2001-06-29

Similar Documents

Publication Publication Date Title
FI892312A (fi) Expression av hepatitis b, s och pres2 proteiner i metylotropiska jaester.
ATE112802T1 (de) Herstellung von funktionellen menschlichen urokinasepolypeptiden.
DE3789399D1 (de) Herstellung von Vakkzinen gegen Hepatitis B-Virus.
ATE159297T1 (de) Expression von menschlichen serumalbumin in methylotrophischen hefen
FI945626A (fi) Menetelmä 2,2-difluoriketeenisilyyliasetaalien ja alfa, alfa-difluori-beta-silyylioksi-1,3-dioksolaani-4-propaanihappoestereiden valmistamiseksi
SE8704157L (sv) Superparamagnetiska partiklar och foerfarande foer framstaellning daerav samt anvaendning
DE69324645T2 (de) Verfahren zur Herstellung von Hepatitis Antigenen und Impfstoffen
AU3597089A (en) Method for producing nonhyperglycosylated hepatitis b virus proteins
DE68923496T2 (de) Verfahren zur Herstellung von motilinähnlichen Polypeptiden und seine Expression.
FR2606281B1 (fr) Antigene du virus de l'hepatite b et procede pour sa production
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
GR3036125T3 (en) Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines.
IE891315L (en) Expression of hepatitis b. pres2 protein in methylotrophic¹yeasts
JPS645492A (en) Production of b type hepatitis virus protein in yeast

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: RESEARCH CORPORATION TECHNOLOGIES, INC.

FG Patent granted

Owner name: RESEARCH CORPORATION TECHNOLOGIES, INC.